SEARCH

SEARCH BY CITATION

References

  • 1
    Allegranzi B , Bagheri NS , Combescure C et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011; 377: 22841.
  • 2
    European Centre For Disease Prevention And Control. Annual epidemiological report on communicable diseases in Europe 2008. 2008, Stockholm.
  • 3
    Vandamme P , Dawyndt P . Classification and identification of the Burkholderia cepacia complex: past, present and future. Syst Appl Microbiol 2011; 34: 8795.
  • 4
    Levy MM , Fink MP , Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference. Intensive Care Med 2003; 29: 5308.
  • 5
    Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement, M100-S22, Vol. 32; Number 3. Wayne: Clinical and Laboratory Standards Institute, 2012.
  • 6
    Wuthiekanun V , Smith MD , Dance DA , White NJ . Isolation of Pseudomonas pseudomallei from soil in north-eastern Thailand. Trans R Soc Trop Med Hyg 1995; 89: 413.
  • 7
    Storms V , Van Den Vreken N , Coeyne T et al. Polyphasic characterisation of Burkholderia cepacia-like isolates leading to the emended description of Burkholderia pyrrocinia . Syst Appl Microbiol 2004; 27: 51726.
  • 8
    Mahenthiralingam E , Bischof J , Byrne SK et al. DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000; 38: 316573.
  • 9
    Baldwin A , Mahenthiralingam E , Thickett KM et al. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol 2005; 43: 466573.
  • 10
    Mahenthiralingam E , Campbell ME , Henry DA , Speert DP . Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol 1996; 34: 291420.
  • 11
    Williams JG , Kubelik AR , Livak KJ , Rafalski JA , Tingey SV . DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res 1990; 18: 65315.
  • 12
    Vonberg RP , Gastmeier P . Hospital-acquired infections related to contaminated substances. J Hosp Infect 2007; 65: 1523.
  • 13
    Mangram A , Jarvis WR . Nosocomial Burkholderia cepacia outbreaks and pseudo-outbreaks. Infect Control Hosp Epidemiol 1996; 17: 71820.
  • 14
    Govan JR , Hughes JE , Vandamme P . Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 1996; 45: 395407.
  • 15
    van Laer F , Raes D , Vandamme P et al. An outbreak of Burkholderia cepacia with septicemia on a cardiology ward. Infect Control Hosp Epidemiol 1998; 19: 1123.
  • 16
    Gravel-Tropper D , Sample ML , Oxley C , Toye B , Woods DE , Garber GE . Three-year outbreak of pseudobacteremia with Burkholderia cepacia traced to a contaminated blood gas analyzer. Infect Control Hosp Epidemiol 1996; 17: 73740.
  • 17
    Centre for Disease Control. Guidelines for prevention of intravascular catheter-related infections. Atlanta: Centre for Disease Control, 2011.
  • 18
    Mattner F , Gastmeier P . Bacterial contamination of multiple-dose vials: a prevalence study. Am J Infect Control 2004; 32: 126.
  • 19
    Cambodia Ministry of Health. Infection prevention and control guidelines for health care facilities. Phnom Penh: Cambodia Ministry of Health, 2010.
  • 20
    World Health Organization. Guidelines for medicine donations. Geneva: World Health Organization, 2011.
  • 21
    Btaiche IF , Kovacevich DS , Khalidi N , Papke LF . The effects of needleless connectors on catheter-related bloodstream infections. Am J Infect Control 2011; 39: 27783.
  • 22
    Chodoff A , Pettis AM , Schoonmaker D , Shelly MA . Polymicrobial gram-negative bacteremia associated with saline solution flush used with a needleless intravenous system. Am J Infect Control 1995; 23: 35763.
  • 23
    Vlieghe E , Kruy L , De Smet B et al. Melioidosis, phnom penh, Cambodia. Emerg Infect Dis 2011; 17: 128992.
  • 24
    Henry DA , Mahenthiralingam E , Vandamme P , Coenye T , Speert DP . Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J Clin Microbiol 2001; 39: 10738.
  • 25
    Trunck LA , Propst KL , Wuthiekanun V et al. Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand. PLoS Negl Trop Dis 2009; 3: e519.
  • 26
    Jassem AN , Zlosnik JE , Henry DA , Hancock RE , Ernst RK , Speert DP . In vitro susceptibility of Burkholderia vietnamiensis to aminoglycosides. Antimicrob Agents Chemother 2011; 55: 225664.
  • 27
    Wuthiekanun V , Amornchai P , Saiprom N et al. Survey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in Northeast Thailand. Antimicrob Agents Chemother 2011; 55: 538891.
  • 28
    Amornchai P , Chierakul W , Wuthiekanun V et al. Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J Clin Microbiol 2007; 45: 37746.